{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:11:55Z","timestamp":1791432715613,"version":"4.3.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific Research Project of Shanghai Municipal Health Commission","award":["201940502"],"award-info":[{"award-number":["201940502"]}]},{"name":"Pudong New Area Science and Technology Development Fund","award":["PKJ2019-Y14"],"award-info":[{"award-number":["PKJ2019-Y14"]}]},{"name":"Exploratory project of Shanghai University of Traditional Chinese Medicine","award":["2020TS099"],"award-info":[{"award-number":["2020TS099"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract <\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The development of risk prediction models for breast cancer lymphedema is increasing, but few studies focus on the quality of the model and its application. Therefore, this study aimed to systematically review and critically evaluate prediction models developed to predict breast cancer-related lymphedema.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Web of Science, Embase, MEDLINE, CNKI, Wang Fang DATA, Vip Database, and SinoMed were searched for studies published from 1 January 2000 to 1 June 2021. And it will be re-run before the final analysis. Two independent investigators will undertake the literature search and screening, and discrepancies will be resolved by another investigator. The Prediction model Risk Of Bias Assessment Tool will be used to assess the prediction models\u2019 risk of bias and applicability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventeen studies were included in the systematic review, including 7 counties, of which 6 were prospective studies, only 7 models were validation studies, and 4 models were externally validated. The area under the curve of 17 models was 0.680~0.908. All studies had a high risk of bias, primarily due to the participants, outcome, and analysis. The most common predictors included body mass index, radiotherapy, chemotherapy, and axillary lymph node dissection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The predictive factors\u2019 strength, external validation, and clinical application of the breast cancer lymphedema risk prediction model still need further research. Healthcare workers should choose prediction models in clinical practice judiciously.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO CRD42021258832<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-022-02084-2","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T09:02:54Z","timestamp":1665651774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal"],"prefix":"10.1186","volume":"11","author":[{"given":"Qiu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yongmei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Mao","family":"Die","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"2084_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"2084_CR2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021:209-249.","DOI":"10.3322\/caac.21660"},{"key":"2084_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00520-018-4334-7","volume":"27","author":"JM Armer","year":"2019","unstructured":"Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, et al. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer. 2019;27:495\u2013503.","journal-title":"Support Care Cancer."},{"key":"2084_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pon.1573","volume":"19","author":"A Chachaj","year":"2010","unstructured":"Chachaj A, Malyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudelko M, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology. 2010;19:299\u2013305.","journal-title":"Psychooncology."},{"key":"2084_CR5","first-page":"23","volume":"5","author":"L Ao","year":"2018","unstructured":"Ao L, Li HM. Qualitative studies on the psychological experience of post-operative patients with breast cancer-related lymphedema: a systematic review. Nurs J Chin PLA. 2018;5:23\u20138.","journal-title":"Nurs J Chin PLA."},{"key":"2084_CR6","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809\u201319.","journal-title":"Cancer."},{"key":"2084_CR7","doi-asserted-by":"publisher","first-page":"b5396","DOI":"10.1136\/bmj.b5396","volume":"340","author":"M Torres Lacomba","year":"2010","unstructured":"Torres Lacomba M, Yuste S\u00e1nchez MJ, Zapico Go\u00f1i A, Prieto Merino D, Mayoral del Moral O, Cerezo T\u00e9llez E, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ (Clinical research ed). 2010;340:b5396.","journal-title":"BMJ (Clinical research ed)."},{"key":"2084_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.23736\/S1973-9087.20.06138-9","volume":"57","author":"T Paolucci","year":"2021","unstructured":"Paolucci T, Bernetti A, Bai AV, Capobianco SV, Bonifacino A, Maggi G, et al. The recovery of reaching movement in breast cancer survivors: two different rehabilitative protocols in comparison. Eur J Phys Rehabil Med. 2021;57:137\u201347.","journal-title":"Eur J Phys Rehabil Med"},{"key":"2084_CR9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00520-020-05567-x","volume":"29","author":"T Paolucci","year":"2021","unstructured":"Paolucci T, Bernetti A, Bai AV, Segatori L, Monti M, Maggi G, et al. The sequelae of mastectomy and quadrantectomy with respect to the reaching movement in breast cancer survivors: evidence for an integrated rehabilitation protocol during oncological care. Support Care Cancer. 2021;29:899\u2013908.","journal-title":"Support Care Cancer."},{"key":"2084_CR10","first-page":"119","volume":"6","author":"Q Lin","year":"2022","unstructured":"Lin Q, Yang T, Yongmei J, Maodie Y. Risk factors associated with breast cancer-related lymphedema: a systematic review and meta-analysis. J Gynecol Reprod Med. 2022;6:119\u201338.","journal-title":"J Gynecol Reprod Med."},{"key":"2084_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijrobp.2019.05.002","volume":"105","author":"JP Gross","year":"2019","unstructured":"Gross JP, Whelan TJ, Parulekar WR, Chen BE, Rademaker AW, Helenowski IB, et al. Development and validation of a nomogram to predict lymphedema after axillary surgery and radiation therapy in women with breast cancer from the NCIC CTG MA.20 randomized trial. Int J Radiat Oncol Biol Phys. 2019;105:165\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2084_CR12","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1007\/s00520-021-06122-y","volume":"29","author":"YF Liu","year":"2021","unstructured":"Liu YF, Liu JE, Zhu Y, Mak YW, Qiu H, Liu LH, et al. Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors. Support Care Cancer. 2021;29:5435\u201345.","journal-title":"Support Care Cancer."},{"key":"2084_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jan.15005","volume":"78","author":"P Martinez-Jaimez","year":"2021","unstructured":"Martinez-Jaimez P, Armora Verdu M, Forero CG, Alvarez Salazar S, Fuster Linares P, Monforte-Royo C, et al. Breast cancer-related lymphoedema: risk factors and prediction model. J Adv Nurs. 2021;78:765\u201375.","journal-title":"J Adv Nurs."},{"key":"2084_CR14","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1245\/s10434-021-09982-0","volume":"28","author":"Q Yuan","year":"2021","unstructured":"Yuan Q, Hou J, Zhou R, Liao Y, Zheng L, Jiao C, et al. Development and validation of an intraoperative nomogram to predict breast cancer-related lymphedema based on the arm lymphatics distribution. Ann Surg Oncol. 2021;28:7319\u201328.","journal-title":"Ann Surg Oncol"},{"key":"2084_CR15","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1007\/s00520-016-3197-z","volume":"24","author":"E Ryu","year":"2016","unstructured":"Ryu E, Yim SY, Do HJ, Lim JY, Yang EJ, Shin MJ, et al. Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation. Support Care Cancer. 2016;24:3767\u201374.","journal-title":"Support Care Cancer."},{"key":"2084_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.breast.2016.06.023","volume":"29","author":"MR Fu","year":"2016","unstructured":"Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, et al. Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast. 2016;29:231\u201340.","journal-title":"Breast."},{"key":"2084_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12885-020-07079-7","volume":"20","author":"E Torgbenu","year":"2020","unstructured":"Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer. 2020;20:604.","journal-title":"BMC Cancer."},{"key":"2084_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13014-019-1243-y","volume":"14","author":"J Rupp","year":"2019","unstructured":"Rupp J, Hadamitzky C, Henkenberens C, Christiansen H, Steinmann D, Bruns F. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast cancer - a long-term observation. Radiat Oncol. 2019;14:39.","journal-title":"Radiat Oncol."},{"key":"2084_CR19","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-1245","volume":"19","author":"SA Norman","year":"2010","unstructured":"Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev. 2010;19:2734\u201346.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2084_CR20","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959\u201372.","journal-title":"Ann Surg Oncol"},{"key":"2084_CR21","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","volume":"24","author":"SA McLaughlin","year":"2017","unstructured":"McLaughlin SA, Staley AC, Vicini F, Thiruchelvam P, Hutchison NA, Mendez J, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: part 1: definitions, assessments, education, and future directions. Ann Surg Oncol. 2017;24:2818\u201326.","journal-title":"Ann Surg Oncol"},{"key":"2084_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1200\/JCO.2015.61.5948","volume":"34","author":"CM Ferguson","year":"2016","unstructured":"Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34:691\u20138.","journal-title":"J Clin Oncol."},{"key":"2084_CR23","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10:e1001381.","journal-title":"PLoS Med."},{"key":"2084_CR24","first-page":"i6460","volume":"356","author":"TP Debray","year":"2017","unstructured":"Debray TP, Damen JA, Snell KI, Ensor J, Hooft L, Reitsma JB, et al. A guide to systematic review and meta-analysis of prediction model performance. BMJ (Clinical research ed). 2017;356:i6460.","journal-title":"BMJ (Clinical research ed)."},{"key":"2084_CR25","doi-asserted-by":"publisher","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","volume":"11","author":"KG Moons","year":"2014","unstructured":"Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11:e1001744.","journal-title":"PLoS Med."},{"key":"2084_CR26","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.","journal-title":"PLoS Med."},{"key":"2084_CR27","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","volume":"170","author":"KGM Moons","year":"2019","unstructured":"Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Int Med. 2019;170:W1\u2013W33.","journal-title":"Ann Int Med"},{"key":"2084_CR28","doi-asserted-by":"publisher","first-page":"102023","DOI":"10.1016\/j.ejon.2021.102023","volume":"54","author":"X Wei","year":"2021","unstructured":"Wei X, Lu Q, Jin S, Li F, Zhao Q, Cui Y, et al. Developing and validating a prediction model for lymphedema detection in breast cancer survivors. Eur J Oncol Nurs. 2021;54:102023.","journal-title":"Eur J Oncol Nurs."},{"key":"2084_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/SLA.0000000000003491","volume":"274","author":"HK Byun","year":"2021","unstructured":"Byun HK, Chang JS, Im SH, Kirova YM, Arsene-Henry A, Choi SH, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective. Ann Surg. 2021;274:170\u20138.","journal-title":"Ann Surg"},{"key":"2084_CR30","first-page":"21","volume":"7","author":"F Li","year":"2020","unstructured":"Li F, Lu Q, Jin S, Zhao Q, Qin X, Jin S, et al. A scoring system for predicting the risk of breast cancer-related lymphedema. Int J Nurs Sci. 2020;7:21\u20138.","journal-title":"Int J Nurs Sci."},{"key":"2084_CR31","doi-asserted-by":"publisher","first-page":"e2024373","DOI":"10.1001\/jamanetworkopen.2020.24373","volume":"3","author":"JYY Kwan","year":"2020","unstructured":"Kwan JYY, Famiyeh P, Su J, Xu W, Kwan BYM, Jones JM, et al. Development and validation of a risk model for breast cancer-related lymphedema. JAMA Network Open. 2020;3:e2024373.","journal-title":"JAMA Network Open."},{"key":"2084_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00520-018-4388-6","volume":"27","author":"IW Penn","year":"2019","unstructured":"Penn IW, Chang Y-C, Chuang E, Chen C-M, Chung C-F, Kuo C-Y, et al. Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study. Support Care Cancer. 2019;27:991\u20131000.","journal-title":"Support Care Cancer."},{"key":"2084_CR33","volume-title":"Risk grade prediction model for breast cancer-related lymphedema","author":"X Yang","year":"2019","unstructured":"Yang X. Risk grade prediction model for breast cancer-related lymphedema. Nanjing: Nanjing Medical University; 2019."},{"key":"2084_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/mhealth.2018.04.02","volume":"4","author":"MR Fu","year":"2018","unstructured":"Fu MR, Wang Y, Li C, Qiu Z, Axelrod D, Guth AA, et al. Machine learning for detection of lymphedema among breast cancer survivors. mHealth. 2018;4:17.","journal-title":"mHealth"},{"key":"2084_CR35","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.amjsurg.2016.08.016","volume":"213","author":"MN Basta","year":"2017","unstructured":"Basta MN, Wu LC, Kanchwala SK, Serletti JM, Tchou JC, Kovach SJ, et al. Reliable prediction of postmastectomy lymphedema: the risk assessment tool evaluating lymphedema. Am J Surg. 2017;213:1125.","journal-title":"Am J Surg"},{"key":"2084_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000443491","volume":"11","author":"L Wang","year":"2016","unstructured":"Wang L, Li HP, Liu AN, Wang DB, Yang YJ, Duan YQ, et al. A scoring system to predict arm lymphedema risk for individual Chinese breast cancer patients. Breast care (Basel, Switzerland). 2016;11:52\u20136.","journal-title":"Breast care (Basel, Switzerland)."},{"key":"2084_CR37","volume-title":"Establishment and evaluation of prediction models for predictng breast cancer related lymphedema","author":"WJ Dou","year":"2016","unstructured":"Dou WJ. Establishment and evaluation of prediction models for predictng breast cancer related lymphedema. Anhui: Anhui Medical University; 2016."},{"key":"2084_CR38","first-page":"2056","volume":"17","author":"HP Li","year":"2014","unstructured":"Li HP, Wang L, Yang YJ, Su D. The establishment and evaluation of scoring system for predicting the risk of postoperative breast cancer-related lymphedema. Chinese. General Practice. 2014;17:2056\u20132061+2069.","journal-title":"General Practice."},{"key":"2084_CR39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","volume":"86","author":"M Kim","year":"2013","unstructured":"Kim M, Kim SW, Lee SU, Lee NK, Jung SY, Kim TH, et al. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86:498\u2013503.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2084_CR40","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1245\/s10434-012-2290-x","volume":"19","author":"JL Bevilacqua","year":"2012","unstructured":"Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol. 2012;19:2580\u20139.","journal-title":"Ann Surg Oncol"},{"key":"2084_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1148\/radiology.167.2.3357976","volume":"167","author":"CB Begg","year":"1988","unstructured":"Begg CB, McNeil BJ. Assessment of radiologic tests: control of bias and other design considerations. Radiology. 1988;167:565\u20139.","journal-title":"Radiology."},{"key":"2084_CR42","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jclinepi.2013.05.014","volume":"66","author":"PF Whiting","year":"2013","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Group Q-S. A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J Clin Epidemiol. 2013;66:1093\u2013104.","journal-title":"J Clin Epidemiol."},{"key":"2084_CR43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285\u201393.","journal-title":"Science."},{"key":"2084_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jama.1994.03510290071040","volume":"271","author":"R Jaeschke","year":"1994","unstructured":"Jaeschke R, Guyatt G, Sackett DL. Users\u2019 guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Jama. 1994;271:389\u201391.","journal-title":"Jama."},{"key":"2084_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12874-016-0267-3","volume":"16","author":"M van Smeden","year":"2016","unstructured":"van Smeden M, de Groot JA, Moons KG, Collins GS, Altman DG, Eijkemans MJ, et al. No rationale for 1 variable per 10 events criterion for binary logistic regression analysis. BMC Med Res Methodol. 2016;16:163.","journal-title":"BMC Med Res Methodol."},{"key":"2084_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jclinepi.2016.02.031","volume":"76","author":"EO Ogundimu","year":"2016","unstructured":"Ogundimu EO, Altman DG, Collins GS. Adequate sample size for developing prediction models is not simply related to events per variable. J Clin Epidemiol. 2016;76:175\u201382.","journal-title":"J Clin Epidemiol."},{"key":"2084_CR47","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/nep.13913","volume":"26","author":"Y de Jong","year":"2021","unstructured":"de Jong Y, Ramspek CL, Zoccali C, Jager KJ, Dekker FW, van Diepen M. Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Nephrology (Carlton). 2021;26:939\u201347.","journal-title":"Nephrology (Carlton)."},{"key":"2084_CR48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691\u20138.","journal-title":"Heart."},{"key":"2084_CR49","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Int Med. 2015;162:W1\u201373.","journal-title":"Ann Int Med"},{"key":"2084_CR50","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/jcm9113427","volume":"9","author":"YI Choi","year":"2020","unstructured":"Choi YI, Park SJ, Chung JW, Kim KO, Cho JH, Kim YJ, et al. Development of machine learning model to predict the 5-year risk of starting biologic agents in patients with inflammatory bowel disease (IBD): K-CDM network study. J Clin Med. 2020;9:3427.","journal-title":"J Clin Med"},{"key":"2084_CR51","first-page":"4","volume":"15","author":"YQ Du","year":"2021","unstructured":"Du YQ, Guan X, Chang DF, Du YY, Li ZJ. Clinical investigation of the risk prediction of postoperative lymphedema in patients after breast conserving surgery for breast cancer based on Bevilacqua model. Chin J Oper Proc Gen Surg( Electronic Edition). 2021;15:4.","journal-title":"Chin J Oper Proc Gen Surg( Electronic Edition)."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-02084-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-022-02084-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-02084-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T09:05:35Z","timestamp":1665651935000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-022-02084-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1186\/s13643-022-02084-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project is a systematic review, and thus, ethics approval is not applicable. Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"All authors agreed in publishing this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}